Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

In ongoing litigation over the safety of its diabetes drug Actos (pioglitazone HCl), Takeda Pharmaceutical Company Limited and its wholly owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., report that in the case of the Whitlatch v. Takeda ,...

Dr. Reddy's Laboratories Ltd. reports that its board of directors has decided to have separate roles of the chairman of the company and the managing director and CEO. It has appointed Satish Reddy as chairman of the board. He...

Actavis plc has announced the proposed senior management team that will lead the specialty pharmaceutical company pending the successful close of the acquisition of Forest Laboratories, Inc., which is anticipated at...

Bristol-Myers Squibb Company and the biopharmaceutical company Celldex Therapeutics have formed a clinical trial collaboration to evaluate the safety, tolerability, and preliminary efficacy of nivolumab, Bristol-Myers Squibb's...

AstraZeneca's MedImmune, its global biologics R&D arm, has formed a clinical study collaboration with the biopharmaceutical company Incyte Corporation. The Phase I/II oncology study will evaluate the efficacy and safety of...

GlaxoSmithKline (GSK) reported disappointing results for its late-stage cardiovascular drug candidate, darapladib, an Lp-PLA2 (lipoprotein-associated phospholipase A2) inhibitor currently being investigated as a potential agent...

In a letter to its shareholders, the specialty pharmaceutical company Valeant Pharmaceuticals International, Inc. said it plans "to improve" its offer for the specialty pharmaceutical company Allergan Inc. following the rejection by...

Health Canada  has suspended the establishment license of Biolyse Pharma Corporation's facility in St. Catharines, Ontario because of "significant concerns" with the manufacturing process discovered during a recent inspection, according to a...